The Baker Company

Pharmacy Isolator Performance Testing


The Baker Company Compounding Isolators and USP Requirements

The United States Pharmacopeia (USP) has recently released an In-Process Revision to Chapter – Pharmaceutical Compounding – Sterile Preparations.1 The Baker Company conducted a study to evaluate its pharmacy isolators using the criteria presented in the In-Process Revision. The results in this paper demonstrate that the SterilSHIELD (compounding aseptic isolator – CAI) and the ChemoSHIELD (compounding aseptic containment isolator – CACI) meet the performance criteria required by the In-Process Revision to USP Chapter when located in an environment worse than ISO Class 7. ISO 5 conditions are maintained when the isolators are challenged with background conditions worse than ISO Class 9. Additionally, these requirements are met without the use of cleanroom garb.

Continue reading the full article

Customer comments

No comments were found for Pharmacy Isolator Performance Testing. Be the first to comment!